m266 caused a dramatic increase in blood and aqueous brain Aβ in J20 mice.
1C22 increased the levels of free Aβ in blood and bound to parenchymal amyloid in J20 mice.
Neither antibody attenuated cognitive deficits or altered brain Aβ oligomers in J20 mice.
Anti-Aβ antibody treatment increased mortality in J20, but not PDAPP mice.
The adverse side-effects and lack of engagement with Aβ oligomers are worrying.